Skip to Main Content

Author Details

Liang Wang
H. Lee Moffitt Cancer Center
1996
114
43
PMIDPaper TitleJournal TitlePublished Year
36704659A review of the mechanisms underlying the role of the <i>GIPC3</i> gene in hereditary deafness.Front Synaptic Neurosci2023
34520569A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.Int J Cancer2022
35432445A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk.Front Genet2022
35711459The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.Front Immunol2022
35875603Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients.Precis Clin Med2022
33724157Cell-free DNA methylome profiling by MBD-seq with ultra-low input.Epigenetics2022
34849858Novel role of prostate cancer risk variant rs7247241 on PPP1R14A isoform transition through allelic TF binding and CpG methylation.Hum Mol Genet2022
35265626The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme.Front Cell Dev Biol2022
33326832The ADCY9 genetic variants are associated with glioma susceptibility and patient prognosis.Genomics2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
33490068The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.Front Cell Dev Biol2021
35053153Dysregulation of DNA Methylation and Epigenetic Clocks in Prostate Cancer among Puerto Rican Men.Biomolecules2021
34520132Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.Cancer Commun (Lond)2021
34680353Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Cancers (Basel)2021
34178690An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma.Front Oncol2021
34234804Distinct Extracellular RNA Profiles in Different Plasma Components.Front Genet2021
33360840ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer.Transl Oncol2021
32256526Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer.Front Genet2020
31971776High-Fidelity Single Molecule Quantification in a Flow Cytometer Using Multiparametric Optical Analysis.ACS Nano2020
31970088Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9.Front Oncol2020
31654347Advantages of Single-Stranded DNA Over Double-Stranded DNA Library Preparation for Capturing Cell-Free Tumor DNA in Plasma.Mol Diagn Ther2020
33217941Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.Cancers (Basel)2020
32571982NRF2-Driven <i>KEAP1</i> Transcription in Human Lung Cancer.Mol Cancer Res2020
32986937Influence of gene expression on survival of clear cell renal cell carcinoma.Cancer Med2020
32752286Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer.Cancers (Basel)2020
32508877A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.Front Genet2020
30958860An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.PLoS One2019
31698791Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.Cancers (Basel)2019
31212602Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer.Cancers (Basel)2019
31323811Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.Genes (Basel)2019
30987362Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma.Cancers (Basel)2019
29789573High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.Nat Commun2018
29858592Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients.Prostate Cancer Prostatic Dis2018
30181389Synergistic Interaction of <i>HOXB13</i> and <i>CIP2A</i> Predisposes to Aggressive Prostate Cancer.Clin Cancer Res2018
29936077Liquid biopsy approach in the management of prostate cancer.Transl Res2018
29959693Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy?Mol Diagn Ther2018
30033361Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.Cell2018
29748005Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.Lung Cancer2018
29661177Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.BMC Cancer2018
27688207Applications of Extracellular RNAs in Oncology.Mol Diagn Ther2017
28969022Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer.Oncotarget2017
29156765Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci.Oncotarget2017
28504856Cell-free DNA copy number variations in plasma from colorectal cancer patients.Mol Oncol2017
28887493Molecular characterization of cell-free eccDNAs in human plasma.Sci Rep2017
28057009Erratum to: Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers.BMC Med Genomics2017
26013599Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus.Mol Carcinog2016
279233663C-digital PCR for quantification of chromatin interactions.BMC Mol Biol2016
27832783miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Mol Cancer2016
27127882Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.Oncotarget2016
26979803Chromatin interactions and candidate genes at ten prostate cancer risk loci.Sci Rep2016
  • 1 - 50 of 114

Recommended Authors

Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 7
Brandy Klotzle
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 5
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 26
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 3
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 15
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 5
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 10
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 4
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 4
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 15
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 18
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 10
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Sonata Jarmalaite
Institute of Biosciences, Vilnius University
Career Start Year 1989
Number of shared co-authors 1
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 10
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 19
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 5
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 4
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 4

Collaborators

Stephen N Thibodeau
Mayo Clinic
Co-authored papers 39
Shannon K McDonnell
Mayo Clinic
Co-authored papers 17
Daniel J Schaid
Mayo Clinic
Co-authored papers 17
Ping Yang
Mayo Clinic
Co-authored papers 15
Ann L Oberg
Co-authored papers 8
Steven J Jacobsen
Kaiser Permanente Southern California
Co-authored papers 7
Gloria M Petersen
Mayo Clinic
Co-authored papers 6
Gong-Hong Wei
Fudan University Shanghai Cancer
Co-authored papers 5
Scott J Hebbring
Marshfield Clinic Research Institute
Co-authored papers 5
Mariza de Andrade
Mayo Clinic
Co-authored papers 4
Nicholas B Larson
Mayo Clinic
Co-authored papers 4
Howard J Jacob
Genomics Research Center
Co-authored papers 4
Noralane M Lindor
Mayo Clinic
Co-authored papers 3
Asha A Nair
Mayo Clinic
Co-authored papers 3
Eric D Wieben
Mayo Clinic Rochester
Co-authored papers 3
Yijun Tian
Naval Medical University
Co-authored papers 3
Jihan Xia
University of Oulu
Co-authored papers 3
Yan W Asmann
Mayo Clinic
Co-authored papers 2
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 2
Elizabeth A Worthey
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 2
Fredrik Wiklund
Co-authored papers 2
Melissa C Larson
Mayo Clinic
Co-authored papers 2
Kevin A T Silverstein
Minnesota Supercomputing Institute, University of Minnesota
Co-authored papers 2
Clive S Grant
Inova Health System
Co-authored papers 2
Christopher I Amos
Baylor College of Medicine
Co-authored papers 2
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 2
Thomas W Glover
University of Michigan ann arbor
Co-authored papers 2
Linnea M Baudhuin
Mayo Clinic
Co-authored papers 2
Christopher A Haiman
University of Southern California
Co-authored papers 2
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Release 1.2